In this Teach Me in 10 episode, Dr. Christina Chang, Director of Assay Applications, Spatial Genomics R&D at Takara Bio USA, ...

Circulogene today announced the national launch of OncoGenDx, an innovative tissue-based comprehensive genomic profiling (CGP ...

Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...

A new era in Indian healthcare has begun with the inception of EarlySure Diagnostics Limited, a visionary venture poised to ...

Key market opportunities in liquid biopsy for early cancer detection include increasing demand for non-invasive diagnosis, ...

According to new statistics released by the Department of Social Protection, the number of applications for Gender ...

The Association for Molecular Pathology released best practice recommendations for improving how complex molecular profiling information is presented to oncologists and other healthcare providers.

Bioanalytical testing market driven by rising biologics, gene therapies, and strict regulations, with growing demand for integrated hybrid assay platforms. BRENTFORD, ENGLAND, UNITED KINGDOM, October ...

Suraksha Diagnostic conducted a scientific session on ‘Advances in Genetics & Reproductive Health’ with international experts ...

Nearly a year after expanding from single cell omics solutions into spatial biology, Takara Bio USA has launched a series of updates to its product portfolio designed to bring its new class of spatial ...

Transgress the NGS has announced a new phase of its Injection Supply Programme for trans folks in universities across Ireland ...